This data was translated to a prospective randomized trial in metastatic ER + breast cancer patients, comparing etrozole + palbociclib to the same regimen preceded by stereotactic body radiation therapy to up to five metastases (NCT04563507). Here, ESR1 is linked to breast cancer.